Literature DB >> 12479927

Hydrogen bonding descriptors in the prediction of human in vivo intestinal permeability.

Susanne Winiwarter1, Fredrik Ax, Hans Lennernäs, Anders Hallberg, Curt Pettersson, Anders Karlén.   

Abstract

Hydrogen bonding has been identified as an important parameter for describing drug permeability. Recently, we derived models for predicting intestinal permeability using the hydrogen bonding descriptors polar surface area (PSA) and number of hydrogen bond donors (HBD), and a lipophilicity descriptor [J. Med. Chem. 41 (1998) 4939]. We have now explored other types of hydrogen bonding descriptors to see if these improve the models. Both an experimental hydrogen bonding descriptor, deltalogP, and calculated descriptors, based either on semiempirical calculations or on experimentally derived hydrogen bond strength values of small molecules, were used. Principal component analyses (PCA) were performed in order to characterize the different parameters, using both a drug data set and a data set of small non-drug-like molecules for which deltalogP-values had been published. For a set of diverse drug molecules, for which human intestinal permeability data was available, a PLS-analysis was performed to study the correlation of permeability to the different hydrogen bonding parameters. No correlation could be identified between deltalogP and human intestinal permeability in this data set. However, the combination of a hydrogen bond donor descriptor, a general hydrogen bonding descriptor and a lipophilicity descriptor enabled the prediction of human intestinal permeability, whereas hydrogen bond acceptor descriptors were found to be less important. The obtained models successfully predicted the intestinal permeability values of two external data sets.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12479927     DOI: 10.1016/s1093-3263(02)00163-8

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  10 in total

1.  An atomistic model of passive membrane permeability: application to a series of FDA approved drugs.

Authors:  Chakrapani Kalyanaraman; Matthew P Jacobson
Journal:  J Comput Aided Mol Des       Date:  2007-11-08       Impact factor: 3.686

2.  The use of BDDCS in classifying the permeability of marketed drugs.

Authors:  Leslie Z Benet; Gordon L Amidon; Dirk M Barends; Hans Lennernäs; James E Polli; Vinod P Shah; Salomon A Stavchansky; Lawrence X Yu
Journal:  Pharm Res       Date:  2008-01-31       Impact factor: 4.200

3.  Skin solubility determines maximum transepidermal flux for similar size molecules.

Authors:  Qian Zhang; Jeffrey E Grice; Peng Li; Owen G Jepps; Guang-Ji Wang; Michael S Roberts
Journal:  Pharm Res       Date:  2009-06-05       Impact factor: 4.200

Review 4.  Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs.

Authors:  Arik Dahan; Jonathan M Miller; Gordon L Amidon
Journal:  AAPS J       Date:  2009-10-30       Impact factor: 4.009

5.  Mechanistic analysis of solute transport in an in vitro physiological two-phase dissolution apparatus.

Authors:  Deanna M Mudie; Yi Shi; Haili Ping; Ping Gao; Gordon L Amidon; Gregory E Amidon
Journal:  Biopharm Drug Dispos       Date:  2012-09-04       Impact factor: 1.627

6.  Salicylic acid transport in Ricinus communis involves a pH-dependent carrier system in addition to diffusion.

Authors:  Françoise Rocher; Jean-François Chollet; Sandrine Legros; Cyril Jousse; Rémi Lemoine; Mireille Faucher; Daniel R Bush; Jean-Louis Bonnemain
Journal:  Plant Physiol       Date:  2009-06-03       Impact factor: 8.340

7.  Modifications of the chemical structure of phenolics differentially affect physiological activities in pulvinar cells of Mimosa pudica L. II. Influence of various molecular properties in relation to membrane transport.

Authors:  Françoise Rocher; Gabriel Roblin; Jean-François Chollet
Journal:  Environ Sci Pollut Res Int       Date:  2016-01-28       Impact factor: 4.223

8.  Amide-to-Ester Substitution as a Strategy for Optimizing PROTAC Permeability and Cellular Activity.

Authors:  Victoria G Klein; Adam G Bond; Conner Craigon; R Scott Lokey; Alessio Ciulli
Journal:  J Med Chem       Date:  2021-12-09       Impact factor: 7.446

9.  Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.

Authors:  Omri Wolk; Riad Agbaria; Arik Dahan
Journal:  Drug Des Devel Ther       Date:  2014-09-24       Impact factor: 4.162

10.  Partial Least Square Model (PLS) as a Tool to Predict the Diffusion of Steroids Across Artificial Membranes.

Authors:  Eleni Tsanaktsidou; Christina Karavasili; Constantinos K Zacharis; Dimitrios G Fatouros; Catherine K Markopoulou
Journal:  Molecules       Date:  2020-03-18       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.